 | Up a level |
Hartinger, C.G.; Hann, S.; Koellensperger, G.; Sulyok, M.; Grössl, Michael; Timerbaev, A.R.; Rudnev, A.V.; Stingeder, G.; Keppler, B.K. (2005). Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins ? significance for the patient. International journal of clinical pharmacology and therapeutics, 43(12), pp. 583-585. Dustri-Verlag 10.5414/CPP43583
